These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23757933)

  • 1. Effect of short peptides containing lysine and epsilon-aminocaproic acid on fibrinolytic activity of plasmin and topoisomerase II action on supercoiled DNA.
    Midura-Nowaczek K; Purwin M; Markowska A; Drozdowska D; Bruzgo M
    Acta Pol Pharm; 2013; 70(3):431-4. PubMed ID: 23757933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors.
    Purwin M; Bruzgo I; Markowska A; Midura-Nowaczek K
    Pharmazie; 2009 Nov; 64(11):765-7. PubMed ID: 20099524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro simulation of thrombolysis inhibition.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):234-7. PubMed ID: 18160584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of some epsilon-aminocaproic acid derivatives on platelet responses.
    Bruzgo I; Tomasiak M; Stelmach H; Midura-Nowaczek K
    Acta Biochim Pol; 2004; 51(1):73-80. PubMed ID: 15094827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antifibrinolytic action of the potato protease inhibitor and epsilon-aminocaproic acid.
    Worowski K
    Acta Biol Acad Sci Hung; 1976; 27(2-3):125-8. PubMed ID: 140568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic activity of epsilon-aminocaproylamino acids in breast cancer MCF-7 and fibroblast cell lines.
    Midura-Nowaczek K; Markowska A; Krajewska D; Wołczyński S
    Acta Pol Pharm; 2010; 67(2):201-4. PubMed ID: 20369798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discreplasminin, a plasmin inhibitor isolated from Tityus discrepans scorpion venom.
    Brazón J; D'Suze G; D'Errico ML; Arocha-Piñango CL; Guerrero B
    Arch Toxicol; 2009 Jul; 83(7):669-78. PubMed ID: 19015833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of epsilon-aminocaproiloaminoacids on the amidolytic activity of tissue plasminogen activator, urokinase and kallikrein.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Markowska A
    Acta Pol Pharm; 2004; 61(1):75-6. PubMed ID: 15259861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbocyclic potential DNA minor groove binders and their biological evaluation.
    Drozdowska D; Bruzgo I; Midura-Nowaczek K
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):629-34. PubMed ID: 20429779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino and chlorambucil analogues of pentamidine--synthesis and biological examinations.
    Pućkowska A; Drozdowska D; Rusak M; Bielawski T; Bruzgo I; Midura-Nowaczek K
    Acta Pol Pharm; 2012; 69(1):63-73. PubMed ID: 22574508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ; Aldridge JH
    Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of epsilon-aminocaproylaminoacids on the activity of proteolytic enzymes.
    Bruzgo I; Midura-Nowaczek K; Roszkowska-Jakimiec W; Jasielczuk J
    Acta Pol Pharm; 2001; 58(2):137-40. PubMed ID: 11501792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N; Moroi M; Tachiya K
    Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric effects of some antifibrinolytic amino acids on the catalytic activity of human plasmin.
    Christensen U
    Biochim Biophys Acta; 1978 Sep; 526(1):194-201. PubMed ID: 150862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ε-aminocaproyl-S-benzyl-L-cysteine on the t-PA activity of human saliva.
    Midura-Nowaczek K; Kaczyńska J; Bruzgo I; Markowska A; Drozdowska D
    Adv Med Sci; 2011; 56(2):323-6. PubMed ID: 22037173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of N epsilon-aminocaproyl-L-norleucine derivatives.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1996; 53(3):221-3. PubMed ID: 8960292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro.
    Yurka HG; Wissler RN; Zanghi CN; Liu X; Tu X; Eaton MP;
    Anesth Analg; 2010 Jul; 111(1):180-4. PubMed ID: 20519417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.